Pharmaceutical company in
Wollerau

Shield TX (Switzerland) AG

Since 2009 · 51–100 empl.

The core activity of Shield Therapeutics plc is the development and marketing of specialized pharmaceuticals, particularly for the treatment of iron deficiency, including anemia. The company focuses on developing medications that improve the lives of people with iron deficiency and has already developed a leading product called ACCRUFeR®, which is approved for the treatment of iron deficiency in adults.

Delta4 AG

Since 2023 · 11–20 empl.

Delta4 AG is a TechBio company that applies AI, systems biology and computational modeling to discover new indications for drugs with established safety profiles. The company operates the Hyper‑C platform and provides in‑silico models, indication‑expansion services and partnering for drug development.

pharma services Oehler GmbH

Since 2006 · 11–20 empl.·5.0(2)

pharma services Oehler GmbH provides pharmaceutical services in quality assurance, regulatory affairs and pharmacovigilance, including preparation of eCTD and other regulatory submission dossiers. The company also advises on food, cosmetic and medical-device related matters and supports market entry into Switzerland.

TACHRIS AG

Since 2008 · 1–10 empl.

Focus Health AG

Since 1965 · 1–10 empl.

Matterhorn AG, Pharmazeutica

Since 1986 · 1–10 empl.

GENERA PHARMA AG

Since 2005 · 1–10 empl.

Alembic Global Holding SA

Since 2007 · 1–10 empl.

Santis Pharma AG

Since 2011 · 1–10 empl.

Burgerstein Apotheke AG

Since 2014 · 1–10 empl.

Shiva Pharmachem SA

Since 2014 · 1–10 empl.

Pharmafox Therapeutics AG

Since 2014 · 1–10 empl.